ES8606357A1 - Procedimiento para la obtencion de oxazolidinonas trisustituidas - Google Patents
Procedimiento para la obtencion de oxazolidinonas trisustituidasInfo
- Publication number
- ES8606357A1 ES8606357A1 ES533017A ES533017A ES8606357A1 ES 8606357 A1 ES8606357 A1 ES 8606357A1 ES 533017 A ES533017 A ES 533017A ES 533017 A ES533017 A ES 533017A ES 8606357 A1 ES8606357 A1 ES 8606357A1
- Authority
- ES
- Spain
- Prior art keywords
- hydrogen
- alk
- formula
- image
- lower alkylene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/40—Halogenated unsaturated alcohols
- C07C33/46—Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts
- C07C33/48—Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts with unsaturation outside the aromatic rings
- C07C33/483—Monocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/04—Saturated ethers
- C07C43/13—Saturated ethers containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/50—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/98—Nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
PROCEDIMIENTO PARA LA OBTENCION DE OXAZOLIDIONONAS TRISUSTITUIDAS. COMPRENDE: A) HACER REACCIONAR UN COMPUESTO DE FORMULA (V) CON UN DERIVADO FUNCIONAL DEL ACIDO CARBONICO DE FORMULA (VI), EN TOLUENO, ENTRE 10 Y 35JC, PARA OBTENER UN COMPUESTO DE FORMULA (III); B) CICLIZAR INTERMOLECULARMENTE EL COMPUESTO DE FORMULA (III), EN PRESENCIA DE AGENTES DE CONDENSACION BASICOS, COMO ALCOHOLATOS, HIDROXIDOS O CARBONATOS DE METALES ALCALINOS O ALCALINO-TERREOS, EN UN DISOLVENTE INERTE, Y BAJO CALENTAMIENTO O ENFRIAMIENTO, PARA OBTENER OXAZOLIDINONAS TRISUSTITUIDAS, DE FORMULA (I). SIENDO: ALK, ALQUILENO INFERIOR; R1, RESTO ARILO O HETEROARILO; R2 Y R3, INDEPENDIENTEMENTE H, O ALQUILO INFERIOR; X1, GRUPO DE SALIDA NUCLEOFUGO; X2 Y X3, ORO; E Y1, NIDROXIETERADO O ESTERIFICADO CAPAZ DE REACCION. SE UTILIZAN COMO ANTIDEPRESIVOS Y ESTIMULANTES NO SIMILARES A LA ANFETAMINA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH301383 | 1983-06-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8606357A1 true ES8606357A1 (es) | 1986-04-01 |
ES533017A0 ES533017A0 (es) | 1986-04-01 |
Family
ID=4246669
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES533017A Expired ES8606357A1 (es) | 1983-06-02 | 1984-05-31 | Procedimiento para la obtencion de oxazolidinonas trisustituidas |
ES546519A Expired ES8702381A1 (es) | 1983-06-02 | 1985-08-29 | Procedimiento para la obtencion de oxazolidinonas trisusti- tuidas |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES546519A Expired ES8702381A1 (es) | 1983-06-02 | 1985-08-29 | Procedimiento para la obtencion de oxazolidinonas trisusti- tuidas |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0128120A3 (es) |
JP (1) | JPS606658A (es) |
KR (1) | KR850000444A (es) |
AU (1) | AU2897984A (es) |
DD (1) | DD223616A5 (es) |
DK (1) | DK272984A (es) |
ES (2) | ES8606357A1 (es) |
FI (1) | FI842159A (es) |
GR (1) | GR82056B (es) |
HU (1) | HUT34981A (es) |
IL (1) | IL71964A0 (es) |
PT (1) | PT78677A (es) |
ZA (1) | ZA844061B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2624861B1 (fr) * | 1987-12-21 | 1990-06-01 | Delalande Sa | Carbamates tricycliques, leur procede de preparation et leur application en therapeutique |
GB201714734D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714740D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714745D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714736D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201903827D0 (en) * | 2019-03-20 | 2019-05-01 | Atrogi Ab | New compounds and methods |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1445729A1 (de) * | 1963-04-06 | 1969-10-02 | Bayer Ag | Verfahren zur Herstellung von Hexahydro-1-aryl-3-imino-3H-oxazolo-[3,4-a]pyridinen |
US3496185A (en) * | 1968-02-14 | 1970-02-17 | Smithkline Corp | Oxazolo- and thiazolo(3,4-a)-pyridine derivatives |
-
1984
- 1984-05-28 EP EP84810263A patent/EP0128120A3/de not_active Withdrawn
- 1984-05-29 ZA ZA844061A patent/ZA844061B/xx unknown
- 1984-05-30 IL IL71964A patent/IL71964A0/xx unknown
- 1984-05-30 FI FI842159A patent/FI842159A/fi not_active Application Discontinuation
- 1984-05-31 ES ES533017A patent/ES8606357A1/es not_active Expired
- 1984-05-31 GR GR74888A patent/GR82056B/el unknown
- 1984-05-31 DD DD84263648A patent/DD223616A5/de unknown
- 1984-06-01 JP JP59111046A patent/JPS606658A/ja active Pending
- 1984-06-01 HU HU842143A patent/HUT34981A/hu unknown
- 1984-06-01 DK DK272984A patent/DK272984A/da not_active Application Discontinuation
- 1984-06-01 KR KR1019840003054A patent/KR850000444A/ko not_active Application Discontinuation
- 1984-06-01 AU AU28979/84A patent/AU2897984A/en not_active Abandoned
- 1984-06-01 PT PT78677A patent/PT78677A/pt unknown
-
1985
- 1985-08-29 ES ES546519A patent/ES8702381A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
ES546519A0 (es) | 1986-12-16 |
PT78677A (en) | 1984-07-01 |
IL71964A0 (en) | 1984-09-30 |
ES8702381A1 (es) | 1986-12-16 |
GR82056B (es) | 1984-12-13 |
ZA844061B (en) | 1985-01-30 |
DK272984D0 (da) | 1984-06-01 |
EP0128120A2 (de) | 1984-12-12 |
DD223616A5 (de) | 1985-06-19 |
EP0128120A3 (de) | 1985-11-13 |
HUT34981A (en) | 1985-05-28 |
FI842159A0 (fi) | 1984-05-30 |
DK272984A (da) | 1984-12-03 |
FI842159A (fi) | 1984-12-03 |
ES533017A0 (es) | 1986-04-01 |
KR850000444A (ko) | 1985-02-27 |
JPS606658A (ja) | 1985-01-14 |
AU2897984A (en) | 1984-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2095444A1 (en) | Fused pyrazine derivatives | |
ES408565A1 (es) | Procedimiento para la preparacion de diaminas ciclicas di- sustituidas en n, n. | |
IL98681A (en) | Pharmaceutical compositions comprising hydroxamate derivatives for iron removal from mammalian cells and from pathogenic organisms and some novel hydroxamate derivatives | |
ES429221A1 (es) | Procedimiento para la preparacion de nuevas amidas de aci- dos n-(1-omega-fenilalcohil)-piperidil-4) - n-(alfa-piridil)-carboxilicos. | |
ES8702381A1 (es) | Procedimiento para la obtencion de oxazolidinonas trisusti- tuidas | |
GB1450010A (en) | Preparation of triamino pyrimidine n-oxides | |
ES417638A1 (es) | Procedimiento para preparar oxazoles 2,4,5-trisustituidos. | |
ES475588A1 (es) | Procedimiento para la obtencion de derivados del acido inde-no -2,1-b- tiofen-2-oxamico | |
ES8203358A1 (es) | Metodo de producir lactamas antihipertensoras | |
ES448389A1 (es) | Procedimiento para la preparacion de isotiazolilureas susti-tuidas. | |
ES8204992A1 (es) | Procedimiento para la obtencion de compuestos poliazahetero-ciclicos | |
ES392848A1 (es) | Un procedimiento para la preparacion de nuevos derivados de indenopirrol. | |
GB1421279A (en) | 3-heterocyclicthiomethylcephalosporins | |
ES373909A1 (es) | Procedimiento para la preparacion de quinazolinas. | |
ES2082971T3 (es) | Esteres de fosfato de acilo y modificacion de proteinas con los mismos. | |
ES422827A1 (es) | Procedimiento para la produccion de benzoilfenilguanidinas. | |
ES8202030A1 (es) | Procedimiento para la preparacion de derivados de rifamicina | |
KR860004040A (ko) | 3,4-디아졸 유도체의 제조방법 | |
ES468532A1 (es) | Un procedimiento para preparar un compuesto de sulfonio re- gulador del crecimiento de las plantas | |
ATE65998T1 (de) | Dihydropyran-derivate. | |
ES394416A1 (es) | Procedimiento para la obtencion de colorantes cationicos. | |
GB1327042A (en) | Oxazole derivatives their preparation and pharmaceutical compositions containing the same | |
JPS51143690A (en) | Benzoo2*44thiazepine | |
CA2175943A1 (en) | Squeak and deletion resistant imaging member and system | |
ES8103748A1 (es) | Procedimiento para la preparacion de 5,6,7,8-tetrahidropira-zolo (3,4-b)(1,5) diazepin-1h,4h-5,7-dionas |